Table 1.
Clinicopathological feature |
TA-NLR |
Univariate analysis |
Multivariate analysis |
|
≤ 0.21 (n = 71) | > 0.21 (n = 71) | P value | P value | |
Age (yr) | 0.322 | |||
≤ 70 | 57 | 52 | ||
> 70 | 14 | 19 | ||
Gender | 0.851 | |||
Male | 52 | 51 | ||
Female | 19 | 20 | ||
Tumor site | 0.099 | |||
Upper | 39 | 26 | ||
Middle | 10 | 15 | ||
Lower | 17 | 18 | ||
Mixed | 5 | 12 | ||
Tumor size (cm) | 0.593 | |||
≤ 3.5 | 25 | 22 | ||
> 3.5 | 46 | 49 | ||
Ki-67 index (%) | 0.081 | |||
≤ 2 | 13 | 6 | ||
≥ 3, ≤ 20 | 8 | 16 | ||
>20 | 50 | 49 | ||
Depth of invasion | 0.044 | 0.406 | ||
T1 | 14 | 8 | ||
T2 | 7 | 3 | ||
T3 | 34 | 29 | ||
T4 | 16 | 31 | ||
Lymph node ratio | 0.043 | 0.355 | ||
0 | 25 | 13 | ||
> 0, ≤ 0.2 | 25 | 24 | ||
> 0.2, ≤ 0.4 | 15 | 18 | ||
> 0.4 | 6 | 16 | ||
Lymphovascular invasion | 0.610 | |||
No | 43 | 40 | ||
Yes | 28 | 31 | ||
ASA status | 0.805 | |||
1 + 2 | 61 | 62 | ||
3 + 4 | 10 | 9 | ||
Postoperative complication | 0.041 | 0.071 | ||
No | 57 | 46 | ||
Yes | 14 | 25 | ||
Surgical approach | 0.855 | |||
Endo/laparoscopic | 49 | 50 | ||
Open | 22 | 21 |
TA-NLR: Tumor-associated neutrophil-to-lymphocyte ratio.